Form 8-K - Current report:
SEC Accession No. 0001193125-24-274870
Filing Date
2024-12-11
Accepted
2024-12-11 07:45:07
Documents
57
Period of Report
2024-12-11
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d901922d8k.htm   iXBRL 8-K 37745
2 EX-99.1 d901922dex991.htm EX-99.1 27923
3 EX-99.2 d901922dex992.htm EX-99.2 44834
7 GRAPHIC g901922ex99_2p10g1.jpg GRAPHIC 337611
8 GRAPHIC g901922ex99_2p11g1.jpg GRAPHIC 159515
9 GRAPHIC g901922ex99_2p12g1.jpg GRAPHIC 335161
10 GRAPHIC g901922ex99_2p13g1.jpg GRAPHIC 328737
11 GRAPHIC g901922ex99_2p14g1.jpg GRAPHIC 257142
12 GRAPHIC g901922ex99_2p15g1.jpg GRAPHIC 305381
13 GRAPHIC g901922ex99_2p16g1.jpg GRAPHIC 341130
14 GRAPHIC g901922ex99_2p17g1.jpg GRAPHIC 296437
15 GRAPHIC g901922ex99_2p18g1.jpg GRAPHIC 277153
16 GRAPHIC g901922ex99_2p19g1.jpg GRAPHIC 223391
17 GRAPHIC g901922ex99_2p1g1.jpg GRAPHIC 226621
18 GRAPHIC g901922ex99_2p20g1.jpg GRAPHIC 260586
19 GRAPHIC g901922ex99_2p21g1.jpg GRAPHIC 209566
20 GRAPHIC g901922ex99_2p22g1.jpg GRAPHIC 397262
21 GRAPHIC g901922ex99_2p23g1.jpg GRAPHIC 167490
22 GRAPHIC g901922ex99_2p24g1.jpg GRAPHIC 344086
23 GRAPHIC g901922ex99_2p25g1.jpg GRAPHIC 122624
24 GRAPHIC g901922ex99_2p26g1.jpg GRAPHIC 278394
25 GRAPHIC g901922ex99_2p27g1.jpg GRAPHIC 178363
26 GRAPHIC g901922ex99_2p28g1.jpg GRAPHIC 84666
27 GRAPHIC g901922ex99_2p29g1.jpg GRAPHIC 316774
28 GRAPHIC g901922ex99_2p2g1.jpg GRAPHIC 581930
29 GRAPHIC g901922ex99_2p30g1.jpg GRAPHIC 250396
30 GRAPHIC g901922ex99_2p31g1.jpg GRAPHIC 123582
31 GRAPHIC g901922ex99_2p32g1.jpg GRAPHIC 398789
32 GRAPHIC g901922ex99_2p33g1.jpg GRAPHIC 242076
33 GRAPHIC g901922ex99_2p34g1.jpg GRAPHIC 320670
34 GRAPHIC g901922ex99_2p35g1.jpg GRAPHIC 211559
35 GRAPHIC g901922ex99_2p36g1.jpg GRAPHIC 387019
36 GRAPHIC g901922ex99_2p37g1.jpg GRAPHIC 109687
37 GRAPHIC g901922ex99_2p38g1.jpg GRAPHIC 305598
38 GRAPHIC g901922ex99_2p39g1.jpg GRAPHIC 441043
39 GRAPHIC g901922ex99_2p3g1.jpg GRAPHIC 121159
40 GRAPHIC g901922ex99_2p40g1.jpg GRAPHIC 562110
41 GRAPHIC g901922ex99_2p41g1.jpg GRAPHIC 335663
42 GRAPHIC g901922ex99_2p4g1.jpg GRAPHIC 428892
43 GRAPHIC g901922ex99_2p5g1.jpg GRAPHIC 160653
44 GRAPHIC g901922ex99_2p6g1.jpg GRAPHIC 354277
45 GRAPHIC g901922ex99_2p7g1.jpg GRAPHIC 381966
46 GRAPHIC g901922ex99_2p8g1.jpg GRAPHIC 239783
47 GRAPHIC g901922ex99_2p9g1.jpg GRAPHIC 358541
48 GRAPHIC g901922g1211112939011.jpg GRAPHIC 5374
  Complete submission text file 0001193125-24-274870.txt   16478951

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cadl-20241211.xsd EX-101.SCH 2512
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cadl-20241211_lab.xml EX-101.LAB 18700
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cadl-20241211_pre.xml EX-101.PRE 11685
59 EXTRACTED XBRL INSTANCE DOCUMENT d901922d8k_htm.xml XML 3849
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Filer) CIK: 0001841387 (see all company filings)

EIN.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40629 | Film No.: 241540151
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)